Health-related quality of life among colorectal cancer survivors of diverse sexual orientations.

cancer survivorship colorectal neoplasms quality of life sexual and gender minorities

Journal

Cancer
ISSN: 1097-0142
Titre abrégé: Cancer
Pays: United States
ID NLM: 0374236

Informations de publication

Date de publication:
15 10 2021
Historique:
revised: 18 05 2021
received: 02 03 2021
accepted: 19 05 2021
pubmed: 9 7 2021
medline: 11 3 2022
entrez: 8 7 2021
Statut: ppublish

Résumé

The purpose of this study was to examine the health-related quality of life of sexual minority survivors in comparison with heterosexual survivors. Four hundred eighty eligible survivors participated in a telephone survey that measured survivors' outcomes, which consisted of physical and mental quality of life and self-rated fair or poor health. These survivors were diagnosed with stage I, II, or III colorectal cancer an average of 3 years before the survey and were recruited from 4 cancer registries. Using forward selection with generalized linear models or logistic regression models, the authors considered 4 domains-personal factors, environmental factors, health condition characteristics, and body function and structure-as correlates for each survivorship outcome. The authors found that unadjusted physical quality of life and self-rated fair/poor health were similar for all survivors. Sexual minority survivors had poorer unadjusted mental quality of life in comparison with heterosexual survivors. After adjustments for covariates, this difference was no longer statistically significant. Three domains (personal factors, health condition characteristics, and body function and structure) explained colorectal cancer survivors' fair/poor health and 46% of the variance in physical quality of life, whereas 56% of the variance in mental quality of life was explained by personal factors, body function and structure, and environmental factors. This study has identified modifiable factors that can be used to improve cancer survivors' quality of life and are, therefore, relevant to ongoing efforts to improve the survivorship experience.

Sections du résumé

BACKGROUND
The purpose of this study was to examine the health-related quality of life of sexual minority survivors in comparison with heterosexual survivors.
METHODS
Four hundred eighty eligible survivors participated in a telephone survey that measured survivors' outcomes, which consisted of physical and mental quality of life and self-rated fair or poor health. These survivors were diagnosed with stage I, II, or III colorectal cancer an average of 3 years before the survey and were recruited from 4 cancer registries. Using forward selection with generalized linear models or logistic regression models, the authors considered 4 domains-personal factors, environmental factors, health condition characteristics, and body function and structure-as correlates for each survivorship outcome.
RESULTS
The authors found that unadjusted physical quality of life and self-rated fair/poor health were similar for all survivors. Sexual minority survivors had poorer unadjusted mental quality of life in comparison with heterosexual survivors. After adjustments for covariates, this difference was no longer statistically significant. Three domains (personal factors, health condition characteristics, and body function and structure) explained colorectal cancer survivors' fair/poor health and 46% of the variance in physical quality of life, whereas 56% of the variance in mental quality of life was explained by personal factors, body function and structure, and environmental factors.
CONCLUSIONS
This study has identified modifiable factors that can be used to improve cancer survivors' quality of life and are, therefore, relevant to ongoing efforts to improve the survivorship experience.

Identifiants

pubmed: 34237147
doi: 10.1002/cncr.33762
pmc: PMC8478814
mid: NIHMS1712751
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

3847-3855

Subventions

Organisme : NCI NIH HHS
ID : R01 CA181392
Pays : United States
Organisme : National Cancer Institute at the National Institutes of Health
ID : 1R01CA181392-01A1

Informations de copyright

© 2021 American Cancer Society.

Références

J Consult Clin Psychol. 2012 Jun;80(3):382-95
pubmed: 22409643
Support Care Cancer. 2020 Jun;28(6):2769-2778
pubmed: 31724075
J Cancer Surviv. 2013 Mar;7(1):32-43
pubmed: 23179495
BMC Cancer. 2018 Oct 22;18(1):1022
pubmed: 30348115
J Geriatr Oncol. 2015 Jul;6(4):299-306
pubmed: 25920578
J Epidemiol Community Health. 2015 Dec;69(12):1199-207
pubmed: 26136082
BMC Psychiatry. 2008 Aug 18;8:70
pubmed: 18706118
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
J Consult Clin Psychol. 2003 Feb;71(1):53-61
pubmed: 12602425
Eur J Epidemiol. 2018 Jun;33(6):591-599
pubmed: 29766438
Psychiatr Serv. 2018 May 1;69(5):572-579
pubmed: 29385953
Am J Public Health. 2016 Feb;106(2):256-63
pubmed: 26691119
J Clin Oncol. 2018 Jul 10;36(20):2088-2100
pubmed: 29775389
Health Serv Res. 2003 Dec;38(6 Pt 2):1735-59
pubmed: 14727795
BMC Cancer. 2011 Sep 21;11:400
pubmed: 21936932
Res Aging. 2004;26(6):655-672
pubmed: 18504506
Oncologist. 2016 Apr;21(4):433-52
pubmed: 26911406
Int J Behav Med. 1997;4(1):92-100
pubmed: 16250744
Psychol Bull. 2003 Sep;129(5):674-697
pubmed: 12956539
Psychooncology. 2019 Jul;28(7):1453-1460
pubmed: 30993811
Cancer. 2020 Jan 1;126(1):112-120
pubmed: 31524952
Health Soc Care Community. 2021 Sep;29(5):1233-1248
pubmed: 33316150
BMC Psychol. 2014 May 30;2(1):12
pubmed: 25566383
J Clin Oncol. 2010 Sep 20;28(27):4154-61
pubmed: 20713876
Lancet Oncol. 2017 Jan;18(1):e39-e50
pubmed: 28049576
Psychooncology. 2018 Jun;27(6):1480-1489
pubmed: 29462496
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Psychoneuroendocrinology. 2013 Aug;38(8):1310-7
pubmed: 23273678
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Nat Rev Urol. 2019 Jul;16(7):404-421
pubmed: 31101896
Med Care. 2005 Jun;43(6):607-15
pubmed: 15908856
J Nurs Meas. 1993 Winter;1(2):165-78
pubmed: 7850498
Qual Life Res. 2007 Nov;16(9):1539-1546
pubmed: 17899447
Qual Life Res. 2012 Mar;21(2):225-36
pubmed: 21660650
Palliat Support Care. 2015 Aug;13(4):875-84
pubmed: 24967597
Women Health. 2006;44(2):81-102
pubmed: 17255060
Soc Sci Med. 1991;32(6):705-14
pubmed: 2035047
PLoS One. 2016 Jun 02;11(6):e0156534
pubmed: 27253385
J Ambul Care Manage. 2001 Jul;24(3):68-86
pubmed: 11433558
Eur J Cancer. 2009 Nov;45(17):3017-26
pubmed: 19765978
J Sex Med. 2016 Mar;13(3):425-34
pubmed: 26853048
Gut. 2009 Aug;58(8):1129-34
pubmed: 19293177
Eur J Oncol Nurs. 2014 Oct;18(5):466-77
pubmed: 24993076
BMJ Open. 2014 Mar 26;4(3):e004461
pubmed: 24670430
LGBT Health. 2019 Aug/Sep;6(6):271-288
pubmed: 31314662
Psychiatr Serv. 2015 Jul;66(7):743-9
pubmed: 25873030
Ann Oncol. 2013 Jun;24(6):1622-30
pubmed: 23448806

Auteurs

Ulrike Boehmer (U)

Department of Community Health Sciences, Boston University School of Public Health, Boston, Massachusetts.

Al Ozonoff (A)

Harvard Medical School, Boston, Massachusetts.
Boston Children's Hospital, Boston, Massachusetts.

Michael Winter (M)

Biostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, Massachusetts.

Flora Berklein (F)

Biostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, Massachusetts.

Jennifer Potter (J)

Harvard Medical School, Boston, Massachusetts.
Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Fenway Institute, Boston, Massachusetts.

Kevan L Hartshorn (KL)

Section of Hematology Oncology, Boston University School of Medicine, Boston, Massachusetts.

Kevin C Ward (KC)

Department of Epidemiology, Emory University, Atlanta, Georgia.

Rachel M Ceballos (RM)

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.

Melissa A Clark (MA)

Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH